Fortune Business Insights has published new insights into the worldwide medicinal cannabis market. The research firm's latest report suggests that the market will reach $26.9204 billion in value by 2026,...
The latest analysis from progressive statistical surveying firm Market Research Future has provided some updated insights into the worldwide medical cannabis market.
Analysts responsible for carrying...
Cannabis pharmaceuticals constitute an ever-growing segment of the global market that, according to analysts at Polaris Market Research, will be worth $5.72 billion by 2027.
Their predictions suggest...
On Wednesday, February 3, Jazz Pharmaceuticals Plc. announced that it had agreed to purchase GW Pharmaceuticals plc in a cash-and-stock deal valued at $7.2 billion.
The goal of this deal is to incorporate...
Canopy Growth Corporation, one of the largest cannabis producers in Canada, has initiated a threatening lawsuit against a United Kingdom-headquartered drugs company called GW Pharmaceuticals.
The...
A cannabis-derived pharmaceutical drug called Epidiolex has officially been banished from the U.S. Drug Enforcement Administration's (DEA) list of controlled substances.
The medicine, which is FDA-approved,...
Following the EU approval of a cannabis-derived epilepsy treatment called Epidiolex, British drugs company GW Pharmaceuticals is experiencing a major surge in sales.
Headquartered in London, GW Pharma...
Cannabis-focused strategy and research consultancy firm Prohibition Partners has published its eagerly awaited Global Cannabis Report. The findings of this report indicate that legal cannabis in North...
British drugs company GW Pharmaceuticals celebrated approval for its cannabinoid-based epilepsy medicine EPIDYOLEX® back in June 2018 in the United States.
Now, EPIDYOLEX has also gained approval...
Cannabis cultivators are expected to reap what they sow on a monumental scale, what with market demand soaring.
Based on a recent report by Grand View Research, Inc., the global market size for cultivation...
Older patients are steering Germany’s medical cannabis market, with the biggest patient group comprising residents aged between 50 and 59 years of age.
This is according to the latest data published...
Major pharmaceutical drug companies are getting involved in legal cannabis, albeit a bit discreetly.
According to recent reports, patents are being snapped up left, right and center, while some pharmaceutical...
